EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)

Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Brad H Rovin, Jonathan Barratt, H Terence Cook, Irene L Noronha, Heather N Reich, Yusuke Suzuki, Sydney C W Tang, Hernán Trimarch, Jürgen Floege

Kidney International · 2025-10 · 108 (4) · S1-S71

DOI: 10.1016/j.kint.2025.04.004 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Kidney International, 2025-10. Verfasst von Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group und 9 weiteren Autor:innen. Die Arbeit wurde bisher 208-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources.

Förderung

  • Boehringer Ingelheim
  • National Institutes of Health

Zitieren

APA

Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Rovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025). KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney International, 108(4), S1-S71. https://doi.org/10.1016/j.kint.2025.04.004

Vancouver

Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Rovin BH, Barratt J, Cook HT, Noronha IL, Reich HN, et al. KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV). Kidney International. 2025;108(4):S1-S71. doi:10.1016/j.kint.2025.04.004

BibTeX
@article{KidneyDiseaseImprovingGlobalOutcomesKDIGOIgANandIgAVWorkGroup2025,
  author = {Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group and Rovin, Brad H and Barratt, Jonathan and Cook, H Terence and Noronha, Irene L and Reich, Heather N and Suzuki, Yusuke and Tang, Sydney C W and Trimarch, Hernán and Floege, Jürgen},
  title = {KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)},
  journal = {Kidney International},
  year = {2025},
  volume = {108},
  number = {4},
  pages = {S1--S71},
  doi = {10.1016/j.kint.2025.04.004}
}
Kostenlos starten →